Related Experiment Video
Updated: Jan 2, 2026

07:38
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
581
Recent Progress on Circular RNA Research in Acute Myeloid Leukemia
Muhammad Jamal1, Tianbao Song1, Bei Chen1
1Department of Immunology, School of Basic Medical Science, Wuhan University, Wuhan, China.
Frontiers in Oncology
|November 30, 2019
Summary
Circular RNAs (circRNAs) are novel non-coding RNAs impacting acute myeloid leukemia (AML) progression. This review details their roles, mechanisms, and potential for AML diagnostics and therapeutics.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Acute myeloid leukemia (AML) is a bone marrow malignancy driven by abnormal myeloid blast proliferation.
- Circular RNAs (circRNAs) are a class of non-coding RNAs with regulatory roles in biological processes.
- Aberrant circRNA expression is implicated in AML progression, but mechanisms are poorly understood.
Purpose of the Study:
- To review the functional roles and research progress of circRNAs in AML.
- To emphasize mechanistic insights into circRNA's role in leukemogenesis.
- To outline challenges and opportunities for circRNA-based diagnostics and therapeutics in AML.
Main Methods:
- Literature review of circRNA research in AML.
- Analysis of studies focusing on circRNA expression and function.
- Synthesis of mechanistic insights and clinical translation potential.
Main Results:
- CircRNAs play significant roles in various biological processes relevant to AML.
- Specific circRNAs are aberrantly expressed in AML, influencing disease progression.
- Mechanistic understanding of circRNA's leukemogenic potential is advancing.
Conclusions:
- CircRNAs represent a promising area for understanding AML pathogenesis.
- Further research into circRNA mechanisms is crucial for clinical applications.
- CircRNA-based diagnostics and therapeutics hold potential for AML treatment.
Related Concept Videos
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Differentiation of Common Myeloid Progenitor Cells
3.8K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.8K

